Previous Chapter Chapter 10: Asia Pacific Markets for Interventional Cardiology Next Chapter

  • Citations
  • Add to My List
  • Text Size

Asia Pacific Markets for Interventional Cardiology
Asia pacific markets for interventional cardiology
Millennium Research Group, A Decision Resources, Inc. Company
Market Overview

In 2005, the Asia Pacific market for interventional cardiology (IC) devices was valued at nearly $600 million, with coronary stents representing the highest-valued segment. Comprising Australia, China (excluding Hong Kong and Taiwan), India, and South Korea, the Asia Pacific market is fueled by the increasing incidence of coronary artery disease (CAD), rising angiography and percutaneous coronary intervention (PCI) procedure volumes, and the rapid uptake of drug-eluting stents (DES). The rapid economic progression is also resulting in better accessibility to interventional treatment, thereby creating tremendous opportunities for market growth. Asia Pacific is one of the fastest-emerging IC markets, and manufacturers are quickly investing more resources into this developing ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website